FDA wants to remove Opana ER from the market that causes serious health condition to the public.
Sharing needles can infect someone with hepatitis C -- and opioid use could be the reason for such rise in hepatitis C cases.
Scientists from Merck & Co., Inc. developed the new drug with the help of a new dihydropyrroloimidazole framework based catalyst.
SOF/VEL/VOX drug combination successfully validated, now under EMA assessment.
The long running Gilead HCV patent case was resolved after the federal jury penalized Gilead and ordered to pay a multibillion dollar compensation.
Expensive Hepatitis C medicines that are believed to cure patients may become a deadly risk for some, says the Food and Drug Administration (FDA).
HCV can increase risks of head and neck cancers, according to studies.
A one pill, once-a-day drug combination that is currently under study showed high cure rates for hepatitis C.
Researchers at UC Irvine Health have developed a cost-effective one-step test that screens, detects and confirms the virus--providing a more advanced version than the current blood-based HCV testing that requires two steps and is rather expensive.